Smethurst Dominic 4

What Happened

• Dominic Smethurst, Chief Medical Officer of Corbus Pharmaceuticals (CRBP), sold 3,285 shares on 2026-02-03. The reported weighted-average price was $8.09, with proceeds of approximately $26,575. This was a sale (not a purchase) and was performed to cover tax withholding obligations tied to RSU vesting.

Key Details

• Transaction date: 2026-02-03; filing date: 2026-02-04 (appears timely).
• Price: weighted average $8.09; actual sale prices ranged $8.01–$8.15 (multiple trades).
• Shares sold: 3,285; reported proceeds ≈ $26,575.
• Shares owned after transaction: the provided filing excerpt does not state total post-transaction beneficial ownership; footnote notes 86,265 unvested RSUs remain subject to each grant's vesting schedule.
• Notable footnotes:
  • F1: Sale was a mandatory "sell to cover" to satisfy tax withholding for RSU vesting (not a discretionary sell by the insider).
  • F2: Price is a weighted average; detailed per-trade prices available on request.
  • F3: Mentions 86,265 unvested RSUs still subject to vesting.

Context

• "Sell to cover" transactions are routine tax-withholding events when RSUs vest; they generally do not signal an insider choosing to reduce a position for investment reasons. This filing reflects tax-related disposition rather than an independent sale decision.